Job Title

2500 University Drive NW Calgary AB T2N 1N4 Canada Job Description The Schulich School of Engineering, in partnership with the Riddell Centre for Cancer Immunotherapy/Charbonneau Cancer Institute, Alberta Childrens Hospital Research Institute (ACHRI), and the Snyder Institute at the University of Calgary, invites national and international applications for a full-time, tenure-track position at the rank of Assistant Professor, with an anticipated start date of May 1, 2026. The successful candidate will be appointed at the rank of Assistant Professor (tenure track) in the Department of Biomedical Engineering. The candidate would be encouraged to apply to be a member of the Charbonneau Cancer Institute, ACHRI and/or Snyder Institute depending on their research. In alignment with the University of Calgary''s Ahead of Tomorrow plan and its strategic academic and research priorities, the successful candidate will actively contribute to research, student and postdoctoral supervision, undergraduate and graduate teaching, curriculum development, and service contributions to the department, faculty and university. Applicants must hold a doctoral degree (or equivalent) in engineering, life sciences, or a related discipline, and a bachelors degree in engineering or equivalent. They should demonstrate an emerging scholarly profile with an original, creative, innovative, and forwardlooking research program, acknowledged by peers as having the potential to become internationally recognized. Applicants should also demonstrate potential for synergies with existing researchers and research groups across campus. The successful candidate is expected to establish a strong research program in Immunoengineering, with the potential to achieve national and international recognition within five to ten years. They will attract competitive external funding, recruit excellent trainees and staff, and contribute to a range of undergraduate and graduate teaching aligned with their expertise. The candidate will provide service to the Department, Faculty, Institutes, University, and broader community, and will contribute to advancing equitable, diverse, inclusive, and accessible employment practices and workplaces. Over time, there will be opportunities to grow into leadership roles within the Department, School, and University. The successful candidates research program will focus broadly in the area of immunerelated engineering (imunoengineering). This may be accomplished through a number of possible topics and applications, including but not limited to: biomimetic materials, immunooncology, molecular engineering, synthetic biology, cellbased therapies, systems immunology and computational immunoengineering, biomanufacturing, or regenerative immunology. Additional areas of interest include advanced invitro model systems such as organonchip and microphysiological platforms for studying immunetissue interactions, as well as translational applications spanning vaccine design and immunomodulatory biomaterials and other diagnostic and/or therapeutic innovations. The successful candidate is expected to be or become eligible for registration as a professional engineer with the Association of Professional Engineers and Geoscientists of Alberta (APEGA) (If any candidates require further information about this criterion, they are encouraged to contact the Department Head. The research area exemplifies the University of Calgarys vision of research that is built around areas of excellence, entrepreneurial thinking, innovation, advanced technology, and strong connections to industry and community. The Schulich School of Engineering is committed to fostering diversity through cultivating an environment where people with a variety of backgrounds, genders, interests and talents feel welcome and included. In 2016, the Schulich School of Engineering was recognized with the KNOVO Award of Distinction to honour the schools commitment to diversity and equity. The Department of Biomedical Engineering, with new teaching labs and renovated research labs, is the home of undergraduate (BSc) and graduate (MEng, MSc, PhD) programs. It anchors crosscampus transdisciplinary activities in Biomedical Engineering, which occur across multiple faculties at the University of Calgary (ucalgary.ca/bme) and involve more than 300 faculty members with current annual research funding exceeding $75M. The university has made significant investments in Biomedical Engineering to date, including the allocation of six Tier1 and nine Tier2 Canada Research Chairs. A strong culture of collaboration and crossdisciplinary research excellence is enabled by significant research infrastructure located in multiple centers across campus. The University of Calgarys transdisciplinary Biomedical Engineering research initiative drives innovations that are saving lives and revolutionizing health care. Biomedical Engineering is led by the Schulich School of Engineering, with the Cumming School of Medicine, and the faculties of Kinesiology, Nursing, Science, and Veterinary Medicine. With collaborative teams focused on human mobility, health monitoring and management including ehealth, advanced biomedical imaging, precision biodiagnostics, regenerative medicine and novel medical technologies, our researchers are transforming health services and quality of life. The Arnie Charbonneau Cancer Institute (charbonneau.ucalgary.ca/) is a partnership between the University of Calgary and Alberta Health Services, bringing together scientists and clinicians to integrate research and care cross disciplines from understanding and preventing cancer, to transforming its detection and treatment, to improving life with and after cancer. In 2023, a generous gift from the Riddell Family, through the Alberta Cancer Foundation, with additional matching funds from the Alberta Childrens Hospital Foundation, enabled the creation of the Riddell Centre for Cancer Immunotherapy (RCCI; at the Arnie Charbonneau Cancer Institute (ACCC), headquartered at the Arthur J.E. Child Comprehensive Cancer Centre (ACCCC), one of the largest comprehensive cancer centres in the world, providing a significant investment into the next phase of cancer immunotherapy research and translation. The RCCIs mission is to reduce the burden of cancer in children, adolescents, and adults by improving disease outcomes through the development of novel immunotherapies. By fostering excellence and teambased science across three major pillars discovery and innovation, biomanufacturing and clinical translation RCCIs mission is to make novel discoveries that translate into improved survival of cancer patients. To achieve this goal the centre integrates novel immunoengineering approaches and produces immune cell therapies through the establishment of a stateoftheart biomanufacturing platform to meet Health Canada and international regulatory standards. With its multidisciplinary team of oncologists, immunologists, pathologists, translational scientists, virologists, cancer modelers, gene scientists, surgeons, imagers, microbiome scientists, computational biologists, cellular engineers, and proteomics specialists with research interests in adult and pediatric cancers, the RCCI program is a strong collaborative environment that is well positioned to be a leader in immune oncology. The successful candidate will benefit from a rich ecosystem, which includes worldclass scholars, a focus on entrepreneurship and innovation, and an equitable, diverse, and inclusive university community that supports transdisciplinary research, partnerships and collaborations, and education excellence. The Schulich School of Engineering Strategic Plan, Schulich Momentum, identifies four pillars: 1) Indigenous Engagement, Inclusivity and Reconciliation; 2) Fostering a Community through Equity, Diversity, Inclusion and Accessibility; 3) Preparing Tomorrows Engineering Changemakers; and 4) Elevating Research and Innovation Impact. The Schulich School of Engineering is a key contributor the University of Calgary Ahead of Tomorrow strategic plan, which emphasizes transdisciplinary scholarship, deeper community integration, and futurefocused program delivery. For more information, please visit the Schulich School of Engineering website. How to Apply Interested candidates are encouraged to submit an application online via the ''Apply Now'' link. Please be aware that the application process allows for only four attachments. Your four application attachments should be organized to contain the following (which may require you to merge documents, such as publications): Cover letter and curriculum vitae, as well as the name and contact information of three referees Statement of research interests, accomplishments and vision. The statement should describe existing and potential collaborations with researchers and research groups locally, nationally, and internationally, as well as have a funding application strategy (maximum 2 pages) Statement of teaching philosophy promoting student learning and success (maximum 2 pages). This can include information on teaching experience, training, and mentoring inside and outside the classroom at the undergraduate, graduate and postdoctoral levels, as well as existing and new courses the applicant could teach Statement on equity, diversity and inclusion (maximum 2 pages) (Applications are accepted until March1,2026 How to Apply Questions may be addressed to: Dr. Michael Kallos Head, Department of Biomedical Engineering Email: [emailprotected] #J-18808-Ljbffr